Status:
RECRUITING
Pharmacologic Induction of Tolerance for Hypoxia & Hypothermia
Lead Sponsor:
University of Maryland, Baltimore
Collaborating Sponsors:
United States Department of Defense
Conditions:
Hypothermia
Hypoxia
Eligibility:
All Genders
18-88 years
Brief Summary
Warfighter Performance Optimization in Extreme Environments remains an area of important and intense investigation, with the following goals: (1) Optimize, sustain and augment medical readiness and ph...
Detailed Description
The investigator's strategy is to: (a) repurpose approved drugs with potential for salutary effect upon RBC performance attributes that contribute to O2 delivery homeostasis during stress and (b) effi...
Eligibility Criteria
Inclusion
- Subject is \>/= 18years of age.
- Subject weighs a minimum of 110lbs
- Subject must be generally healthy individual
Exclusion
- Suspected or diagnosed with ongoing (chronic) or acute infection
- Pregnant
- Non-English speaking
- Ages 89 and over
Key Trial Info
Start Date :
December 11 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 30 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06129825
Start Date
December 11 2023
End Date
July 30 2026
Last Update
January 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Maryland Baltimore
Baltimore, Maryland, United States, 21201